Report Highlights

Investment Casting in the U.S.: Market Overview

The U.S. investment casting market was valued at USD 3.1 billion in 2024 and is forecast to reach USD 4.5 billion by 2032 at a 4.7% CAGR. Output is concentrated in aerospace and defense, where superalloy airfoils, structural housings and missile components account for the majority of shipments. Commercial gas turbines for power generation form the second major block, followed by medical implants, oil and gas valves and industrial pumps.

Policy has shaped this structure as much as demand has. Defense Production Act Title III awards administered through the Department of Defense Office of Industrial Base Policy have targeted castings and forgings for munitions and hypersonic supply chains. Private capital, led by Howmet Aerospace and PCC Structurals, built the commercial single-crystal capacity that dominates engine airfoil supply. Government therefore dominates defense-qualified capacity, while private sector firms lead commercial aerospace and industrial power castings.

Policy-Driven Growth in U.S. Investment Casting

Three federal mechanisms are converting policy into casting demand. First, 10 U.S.C. § 4863 and DFARS 252.225-7009 restrict specialty metal inputs for defense end items to domestically melted or qualifying-country material. Foundries that certify melt traceability win awards that competitors cannot bid, lifting utilization in airfoil and housing programs. Second, Executive Order 14005 and FAR 25.005 set the Buy American domestic content threshold at 65 percent in 2024, rising to 75 percent in 2029, pulling cast components into federally funded systems.

Third, Section 232 of the Trade Expansion Act of 1962, administered by the Bureau of Industry and Security, raised steel and aluminum tariffs to 50 percent in June 2025. That lifts the landed cost of imported castings and master alloys from Asian and Indian foundries. Prime contractors respond by re-sourcing to U.S. capacity, so tariff-driven price gaps shift volume toward domestic casters and compound the defense and power demand already described.

Regulatory Barriers and Compliance Costs

The Occupational Safety and Health Administration enforces the respirable crystalline silica standard at 29 CFR 1910.1053, which sets an 8-hour permissible exposure limit of 50 micrograms per cubic meter. Shell-molding and knockout operations in investment foundries generate the dominant exposure, requiring exposure assessment, engineering controls and medical surveillance. Environmental compliance adds a second layer: the EPA administers 40 CFR Part 63 Subpart EEEEE for iron and steel foundries under the Clean Air Act, with Title V operating permits governing melting and pouring emissions.

Aerospace qualification imposes the longest delays. The FAA administers production approvals under 14 CFR Part 21, and a casting supplier must hold either OEM-issued approval or a parts manufacturer approval under 14 CFR 21.303. Prime contractors also require AS9102 first article inspection, AS9100D quality certification and NADCAP accreditation for heat treatment and nondestructive testing, a process commonly exceeding 18 months and consuming substantial qualification trial spend.

Policy-Created Opportunities in the U.S.

Defense munitions and hypersonic programs offer the most immediate opportunity. Defense Production Act Title III funding, administered by the DoD Office of Industrial Base Policy, targets castings for munitions guidance housings and hypersonic structures where single-source domestic supply is documented. Foundries that secure qualification now gain sole-source positions on multi-year follow-on contracts, a window the Section 232 tariffs reinforce.

Medical implant castings present a second opportunity created by regulation. The FDA's Quality Management System Regulation under 21 CFR Part 820 takes effect on February 2, 2026, aligning device manufacturing requirements with ISO 13485:2016. Orthopedic cobalt-chromium castings must therefore come from suppliers holding ISO 13485 certification, which narrows the approved supplier base and favors certified U.S. foundries over offshore competitors lacking traceable documentation.

Market at a Glance

Leading Market Participants

• Howmet Aerospace
• PCC Structurals
• Doncasters
• Hitchiner Manufacturing
• Consolidated Precision Products
• Cannon-Muskegon
• Pacific Cast Technologies
• Arcast
• Carpenter Technology
• SIFCO Industries

Regulatory and Policy Environment

The primary federal framework rests on the Buy American Act of 1933, codified at 41 U.S.C. §§ 8301–8305, alongside Defense Federal Acquisition Regulation Supplement rules implementing 10 U.S.C. § 4863. The Department of Defense administers DFARS through its acquisition offices, while the FAR Council sets domestic content thresholds under FAR Part 25. Upcoming changes include the Commerce Section 232 processed critical minerals determination, initiated in April 2025 with a statutory report due within 270 days, and the FDA Quality Management System Regulation effective February 2, 2026.

Compared with regional peers, the U.S. framework is narrower but more prescriptive for defense. The European Union regulates foundry emissions through Directive 2010/75/EU on industrial emissions and chemical inputs through REACH, Regulation (EC) No 1907/2006, which imposes broader substance registration on casting consumables. Canada and Mexico operate under USMCA rules of origin effective July 1, 2020, which favor North American castings. Among these peers, U.S. defense sourcing restrictions exceed EU equivalents in specificity and enforcement.

Long-Term Policy Outlook for U.S. Investment Casting

By 2029, the Buy American domestic content threshold reaches 75 percent, forcing federally funded and DoD-linked assemblies to contain majority domestic cast content. Section 232 critical minerals outcomes will set nickel and cobalt duty structures, altering superalloy margins for every U.S. foundry. The Commerce Department will also determine whether tariff exemptions for allied-sourced master alloys remain in place.

OSHA silica enforcement will tighten as exposure monitoring data accumulates, pushing smaller foundries toward consolidation and capital investment in dust controls. The FDA Quality Management System Regulation will concentrate medical casting volume in ISO 13485 certified suppliers, while Clean Air Act Section 112 technology reviews will reset hazardous air pollutant limits for melting furnaces. Market structure will consolidate around certified, traceable, domestically melted capacity by the early 2030s.